Hospitals, state push to reduce infant mortality in Indiana
Indiana is the 10th highest state for children not reaching their first birthday. Hospitals and public officials want to turn that around.
Health Care & Insurance
Articles
Wall Street analysts jumping on Lilly train
For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.
Indy firm specializing in prescription discounts plans to hire 230
Rx Help Centers, which helps insured and uninsured patients extract discounts on brand-name and generic drugs, has grown rapidly since shifting its focus from individuals to employers last year.
Lilly’s Elanco unit buying pet-vaccine portfolio for $885M
The Indianapolis drugmaker's animal-health division is bulking up its companion-animal business by buying Boehringer Ingelheim International's U.S. feline, canine and rabies medications.
Americans getting fed up over high drug prices
A new poll shows that a growing number of people feel drug prices are unreasonable, and they favor a variety of government actions to keep prices down.
St. Vincent loses court battle over $15 million hospital loan
The case centered on an 80-year-old dilapidated hospital in eastern Indiana that St. Vincent bought in 2000. St. Vincent replaced it with a new hospital, called St. Vincent Randolph, at a cost of about $15.5 million.
Analysis: Diabetes drug price war likely to claim more casualties
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.
UPDATE: CNO ends deal with Platinum-tied insurer, to take $55M loss
CNO Financial Group Inc. said it ended a risk-transfer deal with a reinsurer tied to embattled hedge fund Platinum Partners and has filed suit against executives of Beechwood Re. CNO shares tumbled after the news.
Risk-averse CNO caught up in hedge fund nightmare
A deal struck two years ago aimed at offloading the risks associated with a big block of long-term care insurance has come back to haunt the Carmel-based company in a big way.
New firm focuses on innovations, including ‘ear in a dish’
In a Q&A, Monon Bioventures CEO Joe Trebley talks about the goals and ambitions of his one-year-old firm.
Health coalition to push for big tax increase on cigarettes
A broad-based alliance of health and business groups warns that medical costs will keep soaring unless state leaders take steps to promote healthy living, including new restrictions and higher taxes on cigarettes.
Health advocates gain favor to help employees navigate health care complexities
Employers began hiring health advocates in earnest nationwide about four years ago, fueled by implementation of the Affordable Care Act and growing public awareness that provider rates and quality can differ greatly.
Indiana Hospital Association names its next president
Brian Tabor, currently an executive vice president at the organization, will take over as president next year.
Noblesville drug companies terminating 195 employees
Pharmakon Long Term Care Pharmacy Inc. and sister firm Pharmakon Pharmaceuticals Inc. plan to eliminate 195 employees at their headquarters by the end of the week, the owner of the companies said.
IU Health Plans quits Obamacare exchange, citing ‘heightened financial uncertainty’
The move combined with other insurer defections will leave Hoosiers with just five Obamacare marketplace options.
Dental, vision insurance company plans hiring binge
An Indianapolis health insurance company said it plans to add 82 customer-service positions and is holding a job fair Thursday to find candidates.
IU School of Dentistry moves ahead on $21M expansion
It’s the first significant addition in four decades to the 136-year-old institution, the only dental school in Indiana.
Feds seek letters allegedly showing disputes between Anthem, Cigna
Anthem Inc. and Cigna Corp. are refusing to provide letters between the two insurers that the U.S. government contends will show that they get along so poorly that they wouldn’t be able to effectively merge.
The Interview Issue: Dave Ricks
On Jan. 1, Dave Ricks becomes CEO of drugmaker Eli Lilly and Co. as it tries to launch new products after a tough stretch of patent expirations. To prepare, Ricks has spent a lot of time with outgoing CEO John Lechleiter “learning from the master.”
IU, Jackson Lab getting $25M to study Alzheimer’s Disease therapies
The National Institute on Aging is awarding $25 million to the Alzheimer's Disease Precision Models Center, a joint project of the Indiana University School of Medicine in Indianapolis and The Jackson Laboratory in Bar Harbor.